Manager ds. badań klinicznych / Clinical Trial Manager in Surrey, Weybridge

SERB is a fast-growing specialty pharmaceutical company that equips healthcare providers worldwide with life-saving medicines for patients facing rare conditions and emergencies. For over 30 years we have consistently provided emergency medicines, medical countermeasures, and the world’s leading portfolio of antidotes. With a strong presence in the US, UK, Europe, and the Middle East, along with a global network of trusted distribution partners, we make a broad range of essential medicines available in over 100 countries. By expanding our reach through selective acquisitions and entering new markets, we’re not just supplying medicine, we’re improving the standard of care for more patients around the world.

The Senior Director, Medical Oncology provides strategic scientific and clinical leadership for oncology assets across their lifecycle. This role ensures the integration of medical expertise into clinical development plans, medical communications, launch strategies, evidence generation, and external stakeholder engagement. The Senior Director serves as a key bridge between clinical R&D, commercial partners, regulatory affairs, and the external oncology community to support successful development and commercialization of oncology products.

• Develop and shape medical/scientific strategy for SERB’s oncology portfolio for the International markets.
• Integrate competitive intelligence, scientific trends, and regional clinical practice insights into development plans.
• Contribute to long‑term portfolio strategy and monitor evolving oncology science, standards of care, and competitive landscapes to inform strategic decisions.
• Collaborate with all functions, providing medical input, guidance and training.
• Lead International cross‑functional project teams, providing medical direction to Clinical Operations, Regulatory, Safety, Biometrics, and Commercial colleagues.
• Partner with US and EU Medical Affairs teams to support global scientific engagement, publication strategy, and launch readiness.
• Mentor and develop local Medical leads, Clinical Scientists, and regional medical leaders.

• Actively network with international external experts and clinical investigators, gaining insights to inform strategies, developing advocacy through credible scientific exchange, and facilitating collaboration with SERB projects.
• Execute medical affairs strategies, including KOL engagement, medical education, advisory boards, and congress plans, oncology networks.
• Engage in scientific discussions with other external stakeholders such as regulatory authorities, patient advocacy groups and alliance partners globally.
• Support launch readiness activities (indications, label expansions, real-world evidence plans, health economics).
• Lead global advisory boards, investigator meetings, and scientific engagement activities.
• Oversee the direction, strategy and planning of oncology clinical development in International region.
• Ensure quality of relevant clinical documents (e.g. Investigators’ Brochure, study reports, clinical components of regulatory submissions and safety related documents).
• Analyse and interpret clinical data, oversee safety in collaboration with relevant colleagues and participate in data monitoring committee meetings, as required.
• Oversee investigator-initiated studies (IISs), post-marketing studies, real-world evidence initiatives, and data dissemination plans.
• Participate in cross-functional teams to generate, deliver, and interpret high-quality clinical data supporting overall product strategy.
• Ensure all scientific communications are medically accurate, balanced, and compliant.

Ensuring that all interactions and engagements are carried out with the highest ethical and professional standards and that all work is accomplished with quality and in accordance with SERB values.

• Medical degree (MD or equivalent).
• Experience in oncology clinical development Phase II-IV.
• Experience in Medical Affairs leadership roles (minimum 5 years).
• Strategic thinking and expertise in developing strong medical and clinical strategies.
• Strong understanding of global regulatory pathways (FDA, EMA, MHRA).
• Deep scientific and clinical expertise in oncology development.

Benefits include: 25 annual leave days plus bank holidays and 3 annual company closure days (to be taken between Christmas and New Year), competitive pension scheme, private medical insurance, discretionary bonus plan, paid maternity and paternity leave, academic study assistance, eyecare vouchers, and employee assistance programme.